Medicine & Health

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.

Two WashU Medicine researchers have received three-year, $750,000 awards from the Edward P. Evans Foundation to advance the study of certain types of blood cancer.

WashU Medicine researchers have found in mice that two types of immune cells are involved in triggering strong cancer-killing T-cell responses with mRNA vaccines, offering new insights into designing cancer vaccines.

Milan G. Chheda, MD, at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation.

Developed by WashU Medicine researchers and licensed to WashU startup Wugen, the immunotherapy is designed to treat rare and aggressive types of blood cancer.

A new tool developed by WashU Medicine researchers could allow for preemptive treatment of implant-related infections that improves outcomes and reduces patients’ emotional and financial burden.

Ultrasound-guided diffuse optical tomography reduces breast biopsies by 25% in a new study from researchers at Washington University in St. Louis.

Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the bone marrow. The new resource could improve prognosis and guide development of new immunotherapies.

Alex Quillin, PhD ’25, talks about the day she looked through the microscope and realized what she and her fellow students discovered.